It could also be performed on 8/14 additional EATL-II tumours and revealed SETD2 mutations in 6/8 cases, STAT5B mutations in 6/8 cases, and JAK3 and JAK1 mutations in three and one case, respectively (Supplementary Table 5 and Fig. 4a). This evidence concerns the gene JAK1 and enteropathy-associated T-cell lymphoma.